US Broker Ratings

Revvity, Inc. (RVTY) Stock Analysis: Potential 16.53% Upside in Healthcare Diagnostics

Revvity, Inc. (NYSE: RVTY), a key player in the healthcare sector, specifically within the diagnostics and research industry, presents a compelling opportunity for investors seeking to capitalize on its position..

Globus Medical, Inc. (GMED) Stock Analysis: A Promising 13% Upside in the Medical Device Sector

Globus Medical, Inc. (NYSE: GMED) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $11.79 billion, the company has..

Charles River Laboratories (CRL) Stock Analysis: Navigating a Challenging Landscape with Innovation and Strategic Alliances

Charles River Laboratories International, Inc. (NYSE: CRL) remains a pivotal player in the healthcare sector, particularly within diagnostics and research. With a market capitalization of $9.96 billion, Charles River is..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unpacking a Promising 10.64% Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a burgeoning player in the healthcare sector, is making waves in the biotechnology industry. With a market capitalization of $15.08 billion, the company stands out..

Quest Diagnostics (DGX) Stock Analysis: Potential 13.97% Upside Captures Investor Attention

Quest Diagnostics Incorporated (NYSE: DGX), a significant player in the healthcare sector, stands out with a market capitalization of $19.43 billion. This diagnostic and research titan, headquartered in Secaucus, New..

Exact Sciences Corporation (EXAS) Stock Analysis: Unveiling Growth Potential in Cancer Diagnostics

Exact Sciences Corporation (NASDAQ: EXAS), a pivotal player in the healthcare sector, is making waves in the diagnostics and research industry with its innovative cancer screening solutions. With a robust..

Repligen Corporation (RGEN): Investor Outlook with a 15% Upside Potential in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a prominent player in the life sciences sector, is capturing investor attention with its promising growth trajectory and a potential upside of 15.13%. Based in Waltham,..

Universal Health Services, Inc. (UHS) Stock Analysis: Potential Upside Amid Solid Performance Metrics

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, operates an extensive network of acute care and behavioral health facilities across the United States. With a..

Abbott Laboratories (ABT) Stock Analysis: Exploring the 16.52% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth metrics. As a leader in the medical..

Gilead Sciences (GILD) Stock Analysis: Key Insights on Growth, Dividends, and Analyst Ratings

Gilead Sciences, Inc. (GILD) stands as a prominent player in the healthcare sector, primarily focused on the drug manufacturing industry. With a market capitalization of $150.88 billion, Gilead has earned..

Jazz Pharmaceuticals plc (JAZZ): Investor Outlook with a 23% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), headquartered in Dublin, Ireland, is a prominent player in the biotechnology sector, renowned for its innovative drug portfolio aimed at addressing diverse medical needs across..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring Growth Potential with a $110 Billion Market Cap

HCA Healthcare, Inc. (HCA) has firmly established itself as a powerhouse within the medical care facilities industry, boasting an impressive market capitalization of $110.07 billion. As a leading healthcare provider..

Merck & Co., Inc. (MRK) Investor Outlook: Strong Buy Ratings and Promising Upside

As one of the prominent players in the healthcare sector, Merck & Co., Inc. (NYSE: MRK) continues to capture investor attention with its robust portfolio and strategic partnerships. With a..

Chemed Corp (CHE) Investor Outlook: Analysts Eye 35.50% Upside Potential

Chemed Corp (NYSE: CHE), a key player in the healthcare sector with a focus on medical care facilities, presents an intriguing proposition for investors seeking both stability and growth potential...

Qiagen N.V. (QGEN) Stock Analysis: Navigating a 11.91% Potential Upside in Healthcare Diagnostics

Qiagen N.V. (NYSE: QGEN) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Based in Venlo, the Netherlands, this $9.8 billion company is renowned..

Teva Pharmaceutical Industries (TEVA) Stock Report: Analyst Consensus Points to 8.24% Upside Potential

Teva Pharmaceutical Industries Limited (NYSE: TEVA) stands as a formidable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a robust market capitalization of..

UnitedHealth Group (UNH) Stock Analysis: Understanding the 16.6% Potential Upside for Investors

Investors looking for stability and growth in the healthcare sector need look no further than UnitedHealth Group Incorporated (NYSE: UNH). As a heavyweight in the healthcare plans industry, UnitedHealth operates..

GSK plc (GSK) Stock Analysis: Evaluating the Healthcare Giant’s Potential with a Robust 41.52% ROE

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, continues to attract the attention of investors with its diverse portfolio and a strong presence in the global pharmaceutical landscape...

Agilent Technologies (A): Analyzing Growth Potential with a 22% Upside in the Diagnostics Arena

Agilent Technologies, Inc. (NYSE: A), a venerable name in the healthcare sector, particularly within the diagnostics and research industry, is capturing investor attention with its strong market presence and promising..

Medpace Holdings, Inc. (MEDP) Investor Outlook: Navigating a 23.70% Revenue Growth in the Healthcare Sector

Investors eyeing the healthcare sector have likely noticed Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the diagnostics and research industry. Based in Cincinnati, Ohio, Medpace offers a comprehensive..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds